NEFL and Alzheimer disease: In this study, some potential plasma biomarkers (p-Tau181, t-Tau, Aβ42, Aβ40, NfL, TDP-43) were determined by means of a high sensitivity technique (SIMOA) to detect early and specific AD pathology, discriminating from healthy controls and FTLD patients.